Clinical Trial Update: Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating TS-1 as second-line treatment for advanced metastatic breast cancer. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN